首页> 外国专利> Method for preparing dendritic cells with increased specific gene expression, and composition for treating or preventing autoimmune diseases, containing dendritic cells prepared using same

Method for preparing dendritic cells with increased specific gene expression, and composition for treating or preventing autoimmune diseases, containing dendritic cells prepared using same

机译:制备具有增加的特定基因表达的树突状细胞的方法以及用于治疗或预防自身免疫性疾病的组合物,其包含使用该方法制备的树突状细胞

摘要

The present invention relates to a method for generating semi-mature dendritic cells by treating immature dendritic cells with the auto-antigen, cytokine, and PGE2 as a target for the treatment of autoimmune diseases, particularly rheumatoid arthritis, in which the levels of NR4A2 and/or UBASH3B at gene or protein are increased more than 2-fold compared to the immature dendritic cells In addition, the present invention relates to a cell therapeutic agent for treating or preventing autoimmune diseases, containing the semi-mature dendritic cells as an active ingredient. The present invention increases the therapeutic efficacy on rheumatoid arthritis retaining responsiveness to the same auto-antigen that being used for preparing semi-mature dendritic cells, thereby enabling cell therapy.
机译:本发明涉及通过使用自身抗原,细胞因子和PGE 2作为治疗自身免疫疾病,特别是类风湿性关节炎的靶标治疗未成熟树突状细胞来产生半成熟树突状细胞的方法,其中NR4A2和与未成熟树突状细胞相比,基因或蛋白质上的/或UBASH3B增加了两倍以上。此外,本发明涉及一种用于治疗或预防自身免疫疾病的细胞治疗剂,其包含半成熟树突状细胞作为活性成分。 。本发明提高了对类风湿性关节炎的治疗功效,保持了对用于制备半成熟树突状细胞的相同自身抗原的响应性,从而能够进行细胞治疗。

著录项

  • 公开/公告号US10350279B2

    专利类型

  • 公开/公告日2019-07-16

    原文格式PDF

  • 申请/专利权人 JW CREAGENE INC.;

    申请/专利号US201515320010

  • 申请日2015-06-23

  • 分类号C12N5/071;C12N5;C12N5/02;A61K39;A61K35/12;C12Q1/68;C12N5/0784;C12Q1/6881;G01N33/569;

  • 国家 US

  • 入库时间 2022-08-21 12:16:49

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号